NCT02716688 2023-09-22
S-1 and Radiotherapy for Elderly Esophageal Cancer Patients
Zhejiang Provincial People's Hospital
Phase 2 Withdrawn
Clinical Trials
11 trialsNCT05245760 2022-11-08
CRATER
University of Kentucky
Phase 2 Withdrawn
NCT03787251 2022-04-19
A Study of Second-line Treatment of Postoperative Recurrence and Metastasis of Esophageal Cancer Treated With Apatinib
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2 Withdrawn
NCT03220009 2018-10-03
Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma
National Cancer Institute (NCI)
Phase 2 Withdrawn
NCT02274012 2017-03-14
Trial of Afatinib in Combination With Weekly Paclitaxel in the Second Line Treatment
Columbia University
Phase 2 Withdrawn
NCT01301495 2015-06-03
Prospective Evaluation of a New Covered Metal Stent for Malignant Lesions of the Esophagus
Weill Medical College of Cornell University
Phase 2 Withdrawn
NCT02033538 2015-03-05
Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Squamous Cell Carcinoma of Esophagus
Zhejiang University
Phase 2 Withdrawn
NCT02034968 2015-03-05
Nimotuzumab Plus Nab-paclitaxel and Cisplatin in Treating Patients With Advanced Esophageal Carcinoma
Zhejiang University
Phase 2 Withdrawn
NCT02041819 2015-03-05
Neoadjuvant Chemotherapy of Nimotuzumab Plus Nab-Paclitaxel in Squamous Cell Carcinoma of Esophagus
Zhejiang University
Phase 2 Withdrawn
NCT01256203 2014-03-04
Efficacy and Safety of a Sunscreen Against Porfimer Sodium-induced Phototoxicity to Visible Light
Pinnacle Biologics Inc.
Phase 2 Withdrawn
NCT00636298 2013-11-19
Study of Cetuximab and Bevacizumab in Cancer of the Esophagus After Failure of Patient's First Therapy
Emory University
Phase 2 Withdrawn